GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Eric L. Smith, Hani Hassoun et al.|New England Journal of Medicine|2022Cited by 383
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple MyelomaNeha Korde, Ola Landgren, Mark Roschewski et al.|JAMA Oncology|2015Cited by 309
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ola Landgren, Ruth M. Pfeiffer et al.|Blood|2011Cited by 198
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple MyelomaElin Edda Sigurdardottir, Sigurður Y. Kristinsson, Ingemar Turesson et al.|JAMA Oncology|2015Cited by 145
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Ola Landgren, Sham Mailankody et al.|Blood|2012Cited by 127